Mammoth Biosciences

Mammoth Biosciences is engaged in developing products based on CRISPR technology. Among possible applications are diagnostics, genome editing, and protein finding.

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
  • Combo news

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
$  Share Price
Series D 9 Sep 2021
Series C 4 Nov 2020
Series B30 Jan 2020
Series A31 Jul 2018
Seed22 Nov 2017

*** - To view the data, please log into your account or create a new one.

Company valuation calculator

To calculate, specify one of the parameters

News related to Mammoth Biosciences

Mammoth BiosciencesMammoth Biosciences •  8 May 2023

Mammoth Biosciences to Present at the 2023 Annual Meeting of the ...

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as ...
Mammoth BiosciencesMammoth Biosciences • 19 Apr 2023

Curing disease with CRISPR with Trevor Martin from Mammoth ...

This week Darrell and Becca are joined by Trevor Martin the co-founder and CEO of Mammoth Biosciences, a startup that uses CRISPR to diagnose and find ...
Mammoth BiosciencesMammoth Biosciences •  5 Jan 2023

Mammoth Biosciences to Present at 41st Annual J.P. Morgan ...

Mammoth Biosciences to Present at 41st Annual J.P. Morgan Healthcare Conference ...
More (45)